About Syros (SYRS)
Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on redefining the power of small molecules to control the expression of genes. It is focused on developing treatments for cancer and diseases resulting from mutations ... Read more
- USD4.67
- USD4.72
- USD4.40
- USD8.17
- -27.10%
- 10M
- 262.92k
- 286.35k
- 143M
- 2.09
- 69.40%
Stock News
2 hours ago
Is This Beaten-Down Fintech Growth Stock a Better Buy Than SoFi?
Yahoo
2 hours ago
Forget Nvidia and Intel: This Stock Could Be the Biggest Winner of Their New Chip Launches
Yahoo
2 hours ago
Why I Keep Buying This Ultra-High-Yielding ETF for Passive Income
Yahoo
2 hours ago
Could Rivian Become the Next Tesla?
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
